Van Der Meersch H - Search Results

1

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.

De Vriese AS, Caluwé R, Van Der Meersch H, De Boeck K, De Bacquer D. De Vriese AS, et al. Among authors: van der meersch h. J Am Soc Nephrol. 2021 Jun 1;32(6):1474-1483. doi: 10.1681/ASN.2020111566. Epub 2021 Mar 22. J Am Soc Nephrol. 2021. PMID: 33753537 Free PMC article. Clinical Trial.

2

Hemodialysis catheter design and catheter performance: a randomized controlled trial.

Van Der Meersch H, De Bacquer D, Vandecasteele SJ, Van den Bergh B, Vermeiren P, De Letter J, De Vriese AS. Van Der Meersch H, et al. Am J Kidney Dis. 2014 Dec;64(6):902-8. doi: 10.1053/j.ajkd.2014.02.017. Epub 2014 Apr 6. Am J Kidney Dis. 2014. PMID: 24713222 Clinical Trial.

3

Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.

Van Der Meersch H, De Bacquer D, De Vriese AS. Van Der Meersch H, et al. Am Heart J. 2017 Feb;184:37-46. doi: 10.1016/j.ahj.2016.09.016. Epub 2016 Oct 4. Am Heart J. 2017. PMID: 27892885 Review.

4

In reply to 'hemodialysis catheters: which design is more cost-effective?' and 'use of an uncensored primary outcome in a catheter design trial?'.

De Vriese A, Van Der Meersch H, De Bacquer D. De Vriese A, et al. Among authors: van der meersch h. Am J Kidney Dis. 2015 Jul;66(1):171. doi: 10.1053/j.ajkd.2015.04.008. Epub 2015 May 19. Am J Kidney Dis. 2015. PMID: 26002296 No abstract available.

5

Gouty arthritis of the spine in a renal transplant patient: a clinical case report: an unusual presentation of a common disorder.

Dhaese S, Stryckers M, Van Der Meersch H, Terryn W, Van Laecke S. Dhaese S, et al. Among authors: van der meersch h. Medicine (Baltimore). 2015 Apr;94(13):e676. doi: 10.1097/MD.0000000000000676. Medicine (Baltimore). 2015. PMID: 25837758 Free PMC article.

6

Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm.

Vanhee C, Jacobs B, Kamugisha A, Canfyn M, Van Der Meersch H, Ceyssens B, Deconinck E, Van Hoorde K, Willocx M. Vanhee C, et al. Among authors: van der meersch h. Drug Test Anal. 2024 Sep;16(9):957-967. doi: 10.1002/dta.3618. Epub 2023 Dec 3. Drug Test Anal. 2024. PMID: 38043940

7

[Use of orotic acid and orotates].

Van der Meersch H. Van der Meersch H. J Pharm Belg. 2006;61(4):97-104. J Pharm Belg. 2006. PMID: 17263190 Review. French. No abstract available.

8

[Medicinal cannabis].

Van der Meersch H, Verschuere AP, Bottriaux F. Van der Meersch H, et al. J Pharm Belg. 2006;61(3):69-78. J Pharm Belg. 2006. PMID: 17058879 Review. French.

9

[Review of the use of artemisinin and its derivatives in the treatment of malaria].

Van der Meersch H. Van der Meersch H. J Pharm Belg. 2005;60(1):23-9. J Pharm Belg. 2005. PMID: 15828489 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters